Share:
Peer-Reviewed Publication
Radiology2019;292(3):564-572.September 1, 2019Journal Article

Optoacoustic Imaging and Gray-Scale US Features of Breast Cancers: Correlation with Molecular Subtypes.

Basak E Dogan1, Gisela L G Menezes1, Reni S Butler1, Erin I Neuschler1, Roger Aitchison1, Philip T Lavin1, F Lee Tucker1, Stephen R Grobmyer1, Pamela M Otto1, A Thomas Stavros1
1From the Department of Diagnostic Radiology, The University of Texas Southwestern Medical Center, 2201 Inwood Rd, Dallas, TX 75390-8585 (B.E.D.); Department of Radiology, University of Texas Health Science Center at San Antonio, San Antonio, TX (G.L.G.M., P.M.O., A.T.S.); Seno Medical Instruments, San Antonio, TX (G.L.G.M., A.T.S.); Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT (R.S.B.); Department of Radiology, Assistant Professor, Northwestern University Feinberg School of Medicine, Chicago, IL (E.I.N.); Boston Biostatistics Research Foundation, Boston, MA (R.A., P.T.L); Virginia Biomedical Laboratories, LLC, Wirtz, VA (F.L.T.); and Department of Surgical Oncology, Cleveland Clinic, Cleveland, OH (S.R.G.).

Abstract

Background Optoacoustic imaging can assess tumor hypoxia coregistered with US gray-scale images. The combination of optoacoustic imaging and US may have a role in distinguishing breast cancer molecular subtypes. Purpose To investigate whether optoacoustic US feature scores correlate with breast cancer molecular subtypes. Materials and Methods A total of 1972 women (with a total of 2055 breast mass…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.